Biosynthesis of polyketides by trans-AT polyketide synthases

The status of platinum anticancer drugs in the clinic and in clinical trials

Phase I clinical evaluation of [SP-4-3(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4-butanediamine-N,N 1) platinum in patients with metastatic solid tumors

Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule.